Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 1
1955 3
1956 7
1957 2
1958 3
1959 4
1961 4
1962 1
1966 6
1967 29
1968 90
1969 120
1970 125
1971 154
1972 128
1973 175
1974 219
1975 134
1976 145
1977 148
1978 183
1979 176
1980 192
1981 171
1982 187
1983 175
1984 255
1985 271
1986 298
1987 294
1988 304
1989 362
1990 451
1991 500
1992 603
1993 705
1994 708
1995 583
1996 428
1997 433
1998 430
1999 434
2000 510
2001 452
2002 471
2003 520
2004 599
2005 576
2006 517
2007 515
2008 541
2009 530
2010 592
2011 671
2012 693
2013 644
2014 531
2015 545
2016 445
2017 511
2018 457
2019 202
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

19,032 results
Results by year
Filters applied: . Clear all
Page 1
Blocking CGRP in migraine patients - a review of pros and cons.
Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltrán E, Vigneri S, Edvinsson L, Maassen Van Den Brink A; European Headache Federation School of Advanced Studies (EHF-SAS). Deen M, et al. J Headache Pain. 2017 Sep 25;18(1):96. doi: 10.1186/s10194-017-0807-1. J Headache Pain. 2017. PMID: 28948500 Free PMC article. Review.
CGRP Antibodies as Prophylaxis in Migraine.
Edvinsson L. Edvinsson L. Cell. 2018 Dec 13;175(7):1719. doi: 10.1016/j.cell.2018.11.049. Cell. 2018. PMID: 30550780 Free article. Review.
Progress of immunotherapy of anti-α-synuclein in Parkinson's disease.
Wang Z, Gao G, Duan C, Yang H. Wang Z, et al. Biomed Pharmacother. 2019 Jul;115:108843. doi: 10.1016/j.biopha.2019.108843. Epub 2019 May 2. Biomed Pharmacother. 2019. PMID: 31055236 Free article. Review.
Fremanezumab for the prevention of chronic and episodic migraine.
Lionetto L, Cipolla F, Guglielmetti M, Martelletti P. Lionetto L, et al. Drugs Today (Barc). 2019 Apr;55(4):265-276. doi: 10.1358/dot.2019.55.4.2970909. Drugs Today (Barc). 2019. PMID: 31050694 Review.
Brain Peptides for the Treatment of Neuropsychiatric Disorders.
Karatas H, Yemisci M, Eren-Kocak E, Dalkara T. Karatas H, et al. Curr Pharm Des. 2018;24(33):3905-3917. doi: 10.2174/1381612824666181112112309. Curr Pharm Des. 2018. PMID: 30417776 Review.
Reply.
Bearden D, DiGiovine M, Dlugos D, Goldberg E. Bearden D, et al. Ann Neurol. 2016 Mar;79(3):503-4. doi: 10.1002/ana.24597. Epub 2016 Feb 12. Ann Neurol. 2016. PMID: 26749505 No abstract available.
Connexin and pannexin channels in cancer.
Jiang JX, Penuela S. Jiang JX, et al. BMC Cell Biol. 2016 May 24;17 Suppl 1(Suppl 1):12. doi: 10.1186/s12860-016-0094-8. BMC Cell Biol. 2016. PMID: 27229305 Free PMC article. Review.
Delivery of Peptidic Gonadotropin Releasing Hormone Antagonists.
AlSheyyab RY, Al-Taani BM, Obeidat RM, Alsmadi MM, Masaedeh RK, Sabat RN. AlSheyyab RY, et al. Curr Drug Deliv. 2018;15(5):602-609. doi: 10.2174/1567201815666180214142300. Curr Drug Deliv. 2018. PMID: 29446744 Review.
Substance P and its Inhibition in Ocular Inflammation.
Bignami F, Rama P, Ferrari G. Bignami F, et al. Curr Drug Targets. 2016;17(11):1265-74. doi: 10.2174/1389450116666151019100216. Curr Drug Targets. 2016. PMID: 26477461 Review.
19,032 results
Jump to page
Feedback